We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Undiagnosed Thyroid Problems Discovered Through Computerized Screening

By LabMedica International staff writers
Posted on 07 Aug 2012
Scientists in India have developed an improved expert system for the diagnosis of thyroid disease.

Jaganathan Palanichamy and Rajkumar Nallamuthu of the PSNA College of Engineering and Technology (Tamilnadu, India found that the classification of a raw dataset from patient records could allow undiagnosed thyroid problems to be discovered through computerized screening.

The screening algorithm developed by the PSNA team boosts the accuracy of earlier approaches, bringing the level to almost 93.5%, as opposed to earlier tests that had 92% confidence or less. More...
That means that 15 more patients are given neither a false positive nor a false negative of every 1,000 in the screened database.

Over a healthcare network with millions of patients that can amount to significant numbers of people correctly identified with a thyroid problem based on patient records rather than having to carry out specific thyroid function blood tests. The screening approach could also be used by doctors in a clinical setting to assess patients that present with a range of symptoms and so identify with precision whether a thyroid test and subsequent pharmaceutical intervention is required.

Thyroid disease in which either too much thyroid hormone is produced or too little is made are common health problems. An overactive thyroid can lead to increased perspiration, a raised pulse, tremors, anxiety, nervousness and irritability, insomnia, thinning of the skin, fine brittle hair, and muscular weakness. A sluggish thyroid might cause constipation, cold intolerance, decreased sweating, a slow pulse, depression, dry skin, and poor female fertility. Thyroid disease is often asymptomatic and is frequently undiagnosed.

Related Links:

PSNA College of Engineering and Technology




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.